{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:47:13Z","timestamp":1792054033398,"version":"4.4.0"},"reference-count":51,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"unspecified","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG060975"],"award-info":[{"award-number":["R01AG060975"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,9,29]]},"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1136\/bmjopen-2025-109127","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:15:22Z","timestamp":1792052122000},"page":"e109127","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative risk of injury among users of benzodiazepines and related drugs concomitantly with clarithromycin versus azithromycin: a retrospective cohort study of US Medicaid enrollees"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9073-2653","authenticated-orcid":false,"given":"Kacie","family":"Bogar","sequence":"first","affiliation":[{"name":"Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"},{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"},{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Brensinger","sequence":"additional","affiliation":[{"name":"Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"},{"name":"Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengge","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"},{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Hennessy","sequence":"additional","affiliation":[{"name":"Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"},{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"},{"name":"Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh Phuong","family":"Pham Nguyen","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2704-7525","authenticated-orcid":false,"given":"Warren B","family":"Bilker","sequence":"additional","affiliation":[{"name":"Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"},{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"},{"name":"Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"},{"name":"Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A","family":"Miano","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"},{"name":"Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Chung","sequence":"additional","affiliation":[{"name":"Epocrates Inc, Athena Health Care Systems, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Dublin","sequence":"additional","affiliation":[{"name":"Kaiser Permanente, Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA"},{"name":"Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Horn","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Washington School of Pharmacy, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolene","family":"Bressi","sequence":"additional","affiliation":[{"name":"Alliance for Benzodiazepine Best Practices, Portland, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5092-9657","authenticated-orcid":false,"given":"Charles E","family":"Leonard","sequence":"additional","affiliation":[{"name":"Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"},{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"},{"name":"Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"2026101501151161000_16.10.e109127.1","doi-asserted-by":"publisher","DOI":"10.1159\/000524400"},{"key":"2026101501151161000_16.10.e109127.2","unstructured":"O. of the Commissioner . FDA requiring labeling changes for benzodiazepines. 2025. Available: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-requiring-labeling-changes-benzodiazepines"},{"key":"2026101501151161000_16.10.e109127.3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.64719\/pb.4387","article-title":"Oral Muscle Relaxants for the Treatment of Chronic Pain Associated with Cerebral Palsy","volume":"50","author":"Peck","year":"2020","journal-title":"Psychopharmacol Bull"},{"key":"2026101501151161000_16.10.e109127.4","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J"},{"key":"2026101501151161000_16.10.e109127.5","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059040-00014"},{"key":"2026101501151161000_16.10.e109127.6","unstructured":"Bounds CG , Patel P . Benzodiazepines. StatPearls Publishing, 2025."},{"key":"2026101501151161000_16.10.e109127.7","unstructured":"FDA drug safety communication: fda warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. United States Food and Drug Administration; 2024. Available: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or"},{"key":"2026101501151161000_16.10.e109127.8","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2411919121","article-title":"Global trends in antibiotic consumption during 2016\u20132023 and future projections through 2030","volume":"121","author":"Klein","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026101501151161000_16.10.e109127.9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jpsychires.2022.04.033","article-title":"Population-based signals of benzodiazepine drug interactions associated with unintentional traumatic injury","volume":"151","author":"Pham Nguyen","year":"2022","journal-title":"J Psychiatr Res"},{"key":"2026101501151161000_16.10.e109127.10","unstructured":"Drug Development and Drug Interactions . Table of substrates, inhibitors and inducers. United States Food and Drug Administration; 2024. Available: https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/drug-development-and-drug-interactions-table-substrates-inhibitors-and-inducers"},{"key":"2026101501151161000_16.10.e109127.11","unstructured":"Allqvist A . The role of cyp3a4\/5 in alprazolam metabolism. Karolinska Institutet; 2010. Available: https:\/\/openarchive.ki.se\/articles\/thesis\/The_role_of_CYP3A4_5_in_alprazolam_metabolism\/26919295\/1"},{"key":"2026101501151161000_16.10.e109127.12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00953.x"},{"key":"2026101501151161000_16.10.e109127.13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/FPC.0000000000000270","article-title":"PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics\/pharmacodynamics","volume":"27","author":"Fohner","year":"2017","journal-title":"Pharmacogenet Genomics"},{"key":"2026101501151161000_16.10.e109127.14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application","volume":"2","author":"Lund","year":"2015","journal-title":"Curr Epidemiol Rep"},{"key":"2026101501151161000_16.10.e109127.15","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-019-00494-6"},{"key":"2026101501151161000_16.10.e109127.16","first-page":"2024","article-title":"SAS Programs - Claims-Based Frailty Index","volume":"15","author":"Kim","year":"2024","journal-title":"Harvard Dataverse"},{"key":"2026101501151161000_16.10.e109127.17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jac5.1591","article-title":"Research and scholarly methods: Propensity scores","volume":"5","author":"Medaglio","year":"2022","journal-title":"J Am Coll Clin Pharm"},{"key":"2026101501151161000_16.10.e109127.18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.7819"},{"key":"2026101501151161000_16.10.e109127.19","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3697"},{"key":"2026101501151161000_16.10.e109127.20","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/25.4.273"},{"key":"2026101501151161000_16.10.e109127.21","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-012-0284-9"},{"key":"2026101501151161000_16.10.e109127.22","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3390\/pharmaceutics16111449","article-title":"Evaluation of Drug\u2013Drug Interactions Between Clarithromycin and Direct Oral Anticoagulants Using Physiologically Based Pharmacokinetic Models","volume":"16","author":"Yang","year":"2024","journal-title":"Pharmaceutics"},{"key":"2026101501151161000_16.10.e109127.23","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342010-00003"},{"key":"2026101501151161000_16.10.e109127.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2010.09.012"},{"key":"2026101501151161000_16.10.e109127.25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejphar.2007.11.045","article-title":"Flurazepam inhibits the P-glycoprotein transport function: an insight to revert multidrug-resistance phenotype","volume":"581","author":"Lima","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"2026101501151161000_16.10.e109127.26","unstructured":"For Healthcare Professionals . FDA\u2019s examples of drugs that interact with cyp enzymes and transporter systems. United States Food and Drug Administration; 2025. Available: https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/healthcare-professionals-fdas-examples-drugs-interact-cyp-enzymes-and-transporter-systems"},{"key":"2026101501151161000_16.10.e109127.27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s12272-019-01201-5","article-title":"Effects of steady-state clarithromycin on the pharmacokinetics of zolpidem in healthy subjects","volume":"42","author":"Lee","year":"2019","journal-title":"Arch Pharm Res"},{"key":"2026101501151161000_16.10.e109127.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90179-4"},{"key":"2026101501151161000_16.10.e109127.29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1600-0773.1996.tb00191.x","article-title":"Interaction between Erythromycin and the Benzodiazepines Diazepam and Flunitrazepam","volume":"78","author":"Luurila","year":"1996","journal-title":"Pharmacology & Toxicology"},{"key":"2026101501151161000_16.10.e109127.30","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199412000-00003"},{"key":"2026101501151161000_16.10.e109127.31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/psyg.12646","article-title":"Alprazolam and clarithromycin interaction induced lethargy and short-term memory loss in an elderly patient: a case report","volume":"21","author":"Gao","year":"2021","journal-title":"Psychogeriatrics"},{"key":"2026101501151161000_16.10.e109127.32","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2298\/VSP160930383N","article-title":"Exposure to potential drug-antimicrobial agent interactions in primary health care","volume":"75","author":"Nikolic","year":"2018","journal-title":"VSP"},{"key":"2026101501151161000_16.10.e109127.33","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2008.293"},{"key":"2026101501151161000_16.10.e109127.34","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006943009192"},{"key":"2026101501151161000_16.10.e109127.35","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1984.tb03327.x"},{"key":"2026101501151161000_16.10.e109127.36","first-page":"458","article-title":"Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study","volume":"47","author":"Dunner","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"2026101501151161000_16.10.e109127.37","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4088\/JCP.v60n0907","article-title":"Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages","volume":"60","author":"Moroz","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"2026101501151161000_16.10.e109127.38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/j.1875-9114.1981.tb03546.x","article-title":"Evaluation of Temazepam as a Hypnotic","volume":"1","author":"Mitler","year":"1981","journal-title":"Pharmacotherapy"},{"key":"2026101501151161000_16.10.e109127.39","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.sleep.2021.09.005","article-title":"Efficacy and safety of Zolpidem in the treatment of insomnia disorder for one month: a meta-analysis of a randomized controlled trial","volume":"87","author":"Xiang","year":"2021","journal-title":"Sleep Med"},{"key":"2026101501151161000_16.10.e109127.40","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.4170"},{"key":"2026101501151161000_16.10.e109127.41","doi-asserted-by":"publisher","DOI":"10.1136\/injuryprev-2015-041844"},{"key":"2026101501151161000_16.10.e109127.42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00089","article-title":"The Role of Cytochromes P450 in Infection","volume":"9","author":"Stavropoulou","year":"2018","journal-title":"Front Immunol"},{"key":"2026101501151161000_16.10.e109127.43","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24459"},{"key":"2026101501151161000_16.10.e109127.44","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0022-3565(24)36707-2","article-title":"Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects","volume":"281","author":"Bertz","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"2026101501151161000_16.10.e109127.45","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.01790030057007"},{"key":"2026101501151161000_16.10.e109127.46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2011.03591.x"},{"key":"2026101501151161000_16.10.e109127.47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100528","article-title":"Why zolpidem increases the risk of falls and fractures in patients with cirrhosis","volume":"4","author":"Weersink","year":"2022","journal-title":"JHEP Rep"},{"key":"2026101501151161000_16.10.e109127.48","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2003.01852.x"},{"key":"2026101501151161000_16.10.e109127.49","unstructured":"Saunders H , Burns A , Published RR . 5 key facts about medicaid coverage for adults with chronic conditions. KFF. Available: https:\/\/www.kff.org\/medicaid\/issue-brief\/5-key-facts-about-medicaid-coverage-for-adults-with-chronic-conditions\/ [Accessed 23 May 2025]."},{"key":"2026101501151161000_16.10.e109127.50","doi-asserted-by":"publisher","DOI":"10.1089\/POP.2017.0065"},{"key":"2026101501151161000_16.10.e109127.51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/TA.0b013e3182988729","article-title":"American College of Surgeons trauma center verification versus state designation: are Level II centers slipping through the cracks?","volume":"75","author":"Brown","year":"2013","journal-title":"J Trauma Acute Care Surg"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-109127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:15:30Z","timestamp":1792052130000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-109127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,14]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/bmjopen-2025-109127"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-109127","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]}}}